The pharmacoepidemiology of COPD: recent advances and methodological discussion.
Dept of Public Health Services, London, UK. peter.burney@kcl.ac.uk
P
P
Burney
S
S
Suissa
J B
JB
Soriano
W M
WM
Vollmer
G
G
Viegi
S D
SD
Sullivan
L M
LM
Fabbri
D D
DD
Sin
P
P
Ernst
D
D
Coultas
J
J
Bourbeau
D W
DW
Mapel
K
K
Weiss
T
T
McLaughlin
D
D
Price
M C J M
MC
Sturkenboom
R
R
Taylor
G W
GW
Hagan
D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D003362:Cost-Benefit Analysis; D005060:Europe / Q000453:epidemiology; D005260:Female; D005544:Forecasting; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D017891:Pharmacoepidemiology / Q000191:economics / Q000639:trends*; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D011788:Quality of Life; D012129:Respiratory Function Tests; D018570:Risk Assessment; D012720:Severity of Illness Index; D017678:Sex Distribution; D016019:Survival Analysis; D014481:United States / Q000453:epidemiology